Protagonist Therapeutics PTGX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Protagonist Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Protagonist Therapeutics's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Protagonist Therapeutics's operating margin?
- Protagonist Therapeutics (PTGX) reported operating margin of -192.4% in Q1 2026.
- How has Protagonist Therapeutics's operating margin changed year-over-year?
- Protagonist Therapeutics's operating margin decreased by 1568.3% year-over-year, from 13.1% to -192.4%.
- What is the long-term trend for Protagonist Therapeutics's operating margin?
- Over 3 years (2021 to 2025), Protagonist Therapeutics's operating margin has grown at a -9.3% compound annual growth rate (CAGR), from -460% to -343.6%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.